Archive · 2 Sep 2025
Invicta Diagnostic IPO Approved for Maharashtra Expansion
Invicta Diagnostic, a company running medical test centers, got approval to sell shares to raise money.
They plan to get about ₹28 crore to open five more centers in Maharashtra.
They will use this money to buy equipment and expand their business.
Invicta already has seven centers.
They offer many different tests for patients.
The company wants to provide more tests to help more people in different cities.
Invicta Diagnostic received in-principle approval for its IPO from NSE Emerge.
The company plans to raise approximately ₹28 crore through the IPO.
Funds will be used to establish five new diagnostic centers in Maharashtra.
The company's revenue from operations stood at ₹30.09 crore in FY25.
Invicta offers a wide range of pathology and radiology tests.
- Who
- Invicta Diagnostic Ltd
- What
- Received in-principle approval for its IPO and plans to expand
- When
- Approved in June 2025, published in September 2025
- Where
- Maharashtra, India
- Why
- To expand diagnostic services
- Company
- Invicta Diagnostic Ltd
- IPO Approval
- In-principle from NSE Emerge
- Planned Funds Raised
- ₹28 crore
- Use of Funds
- Establish five new diagnostic centers in Maharashtra
- FY25 Revenue
- ₹30.09 crore
- FY25 Profit After Tax
- ₹4.92 crore
- Founded By
- Dr. Ketan Jayantilal Jain and Dr. Sanket Vinod Jain